Antibodies that bind TAT294
The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
1. An isolated antibody which binds to:
(a) the polypeptide shown in FIG. 2 (SEQ ID NO:2);
(b) the polypeptide shown in FIG. 2 (SEQ ID NO:2), lacking its associated signal peptide;
(c) the polypeptide encoded by the full-length coding sequence of the nucleotide sequence shown in FIG. 1 (SEQ ID NO:1);
(d) the polypeptide encoded by the full-length coding sequence of the nucleotide sequence shown in FIG. 1 (SEQ ID NO:1), lacking its associated signal peptide;
(e) the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 203127; or
(f) the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 203127, lacking its associated signal peptide.
2. The antibody of claim 1 which is a monoclonal antibody.
3. The antibody of claim 1 which is an antibody fragment.
4. The antibody of claim 1 which is a chimeric, human, or humanized antibody.
5. The antibody of claim 1 which is produced in bacteria.
6. The antibody of claim 1 which is produced in CHO cells.
7. The antibody of claim 1 which induces death of a cell to which it binds.
8. The antibody of claim 1 which is detectably labeled.